Bionet Market Cap ($81.60 Million)
Market Cap & Net Worth: Bionet (1784)
Bionet market cap. Bionet (TWO:1784) has a market capitalization of $81.60 Million (NT$2.59 Billion) as of November 1, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #19788 globally and #1159 in its home market, demonstrating a -9.53% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bionet's stock price NT$49.85 by its total outstanding shares 51957191 (51.96 Million). Also see Bionet (1784) cash flow conversion for how efficiently the company converts equity into cash flow.
Bionet Market Cap History (2015–2026)
Bionet market cap history from 2015 to 2026. Data shows growth from $58.14 Million to $81.60 Million (4.25% CAGR). Check Bionet stock price for real-time trading data and today's change.
Bionet Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bionet's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Bionet growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.14x
Bionet's market cap is 0.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.29x
Bionet's market cap is 3.29 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $43.10 Million | $697.40 Million | -$6.27 Million | 0.06x | N/A |
| 2018 | $42.14 Million | $770.61 Million | $24.23 Million | 0.05x | 1.74x |
| 2019 | $65.16 Million | $775.56 Million | $6.80 Million | 0.08x | 9.58x |
| 2020 | $65.12 Million | $806.58 Million | $12.74 Million | 0.08x | 5.11x |
| 2021 | $64.09 Million | $921.42 Million | $26.62 Million | 0.07x | 2.41x |
| 2022 | $71.86 Million | $980.38 Million | $37.97 Million | 0.07x | 1.89x |
| 2023 | $95.11 Million | $1.13 Billion | $78.40 Million | 0.08x | 1.21x |
| 2024 | $130.14 Million | $1.22 Billion | $83.70 Million | 0.11x | 1.55x |
| 2025 | $169.42 Million | $1.24 Billion | $51.43 Million | 0.14x | 3.29x |
Competitor Companies of 1784 by Market Capitalization
Companies near Bionet in the global market cap rankings as of November 1, 2026. Also see 1784 asset base for a full breakdown of the balance sheet.
Key companies related to Bionet by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $164.04 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #530 globally with a market cap of $51.40 Billion USD ( CN¥351.23 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $697.00 |
| #143 | Danaher Corporation | NYSE:DHR | $164.04 Billion | $232.23 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $414.30 |
| #530 | WuXi AppTec Co Ltd | SHG:603259 | $51.40 Billion | CN¥142.01 |
Market Capitalization of Bionet (2015–2026)
Market capitalization of Bionet from 2015 to today. Between 2015 and today, Bionet's market cap moved from $58.14 Million to $ 81.60 Million, with a yearly change of 4.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$81.60 Million | -51.84% |
| 2025 | NT$169.42 Million | +30.19% |
| 2024 | NT$130.14 Million | +36.83% |
| 2023 | NT$95.11 Million | +32.35% |
| 2022 | NT$71.86 Million | +12.12% |
| 2021 | NT$64.09 Million | -1.58% |
| 2020 | NT$65.12 Million | -0.06% |
| 2019 | NT$65.16 Million | +54.63% |
| 2018 | NT$42.14 Million | -2.22% |
| 2017 | NT$43.10 Million | -10.89% |
| 2016 | NT$48.37 Million | -16.81% |
| 2015 | NT$58.14 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Bionet was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $81.60 Million USD |
| MoneyControl | $81.60 Million USD |
| MarketWatch | $81.60 Million USD |
| marketcap.company | $81.60 Million USD |
| Reuters | $81.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bionet
BIONET Corp. engages in cell therapy, regenerative medicine, medical big data, gene testing, and sales of biological and scientific information hardware and software business in Taiwan and internationally. The company offers stem cell banking services, such as stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC and immune cells, as well as skin … Read more